Dr. Aaron Ritter is the primary investigator for clinical trials of the drug, aducanumab, at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas. (Chase Stevens/Las Vegas Review-Journal) @csstevensphoto
Dr. Aaron Ritter is the primary investigator for clinical trials of the drug, aducanumab, at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas. (Chase Stevens/Las Vegas Review-Journal) @csstevensphoto